DOI QR코드

DOI QR Code

Cost of Treatment for Cancer: Experiences of Patients in Public Hospitals in India

  • Nair, Kesavan Sreekantan (National Institute of Health and Family Welfare) ;
  • Raj, Sherin (National Institute of Health and Family Welfare) ;
  • Tiwari, Vijay Kumar (National Institute of Health and Family Welfare) ;
  • Piang, Lam Khan (Jawaharlal Nehru University)
  • Published : 2013.09.30

Abstract

Background: To assess the treatment pattern and expenditure incurred by cancer patients undergoing treatment at government tertiary hospitals in India. Materials and Methods: A cross-sectional study of 508 cancer patients randomly selected from tertiary cancer hospitals funded by central/state governments located in major cities of five states in India, namely Kerala, Maharashtra, Rajasthan, West Bengal and Mizoram, during March - May 2011 was conducted. Information related to direct costs, indirect costs and opportunity costs incurred on investigations and treatment, major source of payment and difficulties faced by patients during the course of treatment was collected. Results: About 45% of the patients used private health facilities as the first point of contact for cancer related diseases as against 32% in public hospitals. About 47% sought private health facilities for cancer investigations, 21% at district/sub-district hospitals, and about 4% contacted primary health care facilities. A majority of the patients (76%) faced financial problems while undergoing treatment. Conclusions: The results highlight the importance of involving the primary health care system in the cancer prevention activities.

Keywords

Cancer;cost of treatment;investigations;direct cost;indirect cost

References

  1. Government of India (2005). Report of the National Commission On Macroeconomics And Health. Ministry of Health & Family Welfare, New Delhi.
  2. Government of India (2010). Annual Report 2009-10, Ministry of Health & Family Welfare, New Delhi.
  3. Government of India (2012). 12th Five Year Plan (2012-2017), Planning Commission, New Delhi.
  4. Goyal S (2013). Cost of Oral Cancer in a Super-speciality Private Hospital in Delhi. Unpublished M.D. thesis, National Institute of Health and Family Welfare, New Delhi.
  5. Mohanti BK, Mukhopadhyay A, Das S, Sharma K, Dash S (2011). Estimating the economic burden of cancer at a tertiary public hospital: a study at the all India Institute of Medical Sciences, Discussion Paper 11-09.
  6. Han S, Chen Y, Ge X, et al (2010). Epidemiology and Cost Analysis for Patients with Oral Cancer in a University Hospital in China. BMC Public Health, 10, 196. https://doi.org/10.1186/1471-2458-10-196
  7. Lan NH, Laohasiriwong W, Stewart JF, Tung ND, Coyte PC (2013). Cost of treatment for breast cancer in central Vietnam. Global Health Action, 6, 18872. https://doi.org/10.3402/gha.v6i0.18872
  8. Mahal A, Karan A, Engelgau M (2010). The economic implications of non-communicable diseases for India. Washington DC: World Bank.
  9. Mukhopadhyay A, Mohanti KB, Sharma K, Das S, Dash S (2011). The economic burden of cancer, Economic and Political Weekly, 47, 43.
  10. Raj S, Piang LK, Nair KS, et al (2012). Awareness regarding risk factors, symptoms and treatment facilities for cancer in selected states of India. Asian Pac J Cancer Prev, 13, 4057-62. https://doi.org/10.7314/APJCP.2012.13.8.4057
  11. Sharma EK (2013). Killer cost. Business today, Avaliable from http://businesstoday.intoday.in/story/cancer-treatmentcost/1/191785.html.
  12. WHO (2008). International Agency for Research on Cancer. World Cancer Report.

Cited by

  1. Non-communicable diseases in South Asia: contemporary perspectives vol.111, pp.1, 2014, https://doi.org/10.1093/bmb/ldu018
  2. Feasibility of Computed Tomography Colonography as a Diagnostic Procedure in Colon Cancer Screening in India vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5111
  3. Risk Factors and Costs of Oral Cancer in a Tertiary Care Hospital in Delhi vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1659
  4. Financial Distress and its Predicting Factors among Iranian Cancer Patients vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1621
  5. Cancer Detection Rates in a Population-Based, Opportunistic Screening Model, New Delhi, India vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1953
  6. Cost of hospitalisation for non-communicable diseases in India: are we pro-poor? vol.21, pp.8, 2016, https://doi.org/10.1111/tmi.12732
  7. Curcumin Nanotechnologies and Its Anticancer Activity vol.69, pp.3, 2017, https://doi.org/10.1080/01635581.2017.1285405
  8. The economic impact of non-communicable diseases among households in South Asia and their coping strategy: A systematic review vol.13, pp.11, 2018, https://doi.org/10.1371/journal.pone.0205745
  9. Economic Studies on Non-Communicable Diseases and Injuries in India: A Systematic Review vol.16, pp.3, 2018, https://doi.org/10.1007/s40258-018-0370-1